Presentation

Who Are We?

Our company specializes in the following areas:

The design and marketing of single-use medical devices.
The production and distribution of solid solutions as well as other injectable medications.
The installation and maintenance of various medical equipment (Dialysis machines, water treatment systems, apheresis, and in vitro diagnostics).
The care of hemodialysis patients through our 17 Renadial clinics. Staff: 1665 employees at IMC / 500 at Renadial.

IMC is a company dedicated to the healthcare sector, with 30 years of experience in the management of chronic diseases, particularly CKD (Chronic Kidney Disease) through hemodialysis.

We are actively committed to local manufacturing investment, with a recognized pharmaceutical industrial infrastructure (6 production units located in industrial zones in Algiers).

We comply with current international standards (GMP, ISO 9001 since 2001, CE Marking since 2006) and have directed our strategy towards export since our inception.

Our Certificates

ISO 9001

The ISO 9001 certification attests to our commitment to a rigorous quality management system. It guarantees that our processes are standardized, efficient, and focused on customer satisfaction.

ISO 13485

The ISO 13485 standard is specific to medical devices. It demonstrates our ability to provide medical products that comply with the strictest regulatory and safety requirements.

CE Marking

The CE marking confirms the conformity of our products to European safety and performance standards. It demonstrates our commitment to adhering to the most demanding market regulations.

Exporting

For over 30 years, IMC has positioned itself as a major player in the export of single-use medical devices, radiating far beyond Algerian borders.

Our export strategy is based on impeccable quality, rigorous international certifications, and a comprehensive range of innovative medical products tailored to the needs of international markets.

We primarily export to Africa and the Middle East, offering high-precision medical solutions, particularly in the fields of hemodialysis, surgical devices, and pharmaceutical consumables.

Our Story

1989

Creation of IMC, a privately-owned company, marking the beginning of an adventure in the healthcare sector.

1994

Start of marketing dialysis equipment, responding to a growing need in the medical field.

1998

Launch of syringe manufacturing, an essential product for daily medical care.

2002

Inauguration of the first massive solutions unit, in partnership with Aguettant laboratories, strengthening our production capacity.

2002

Creation of the Renadial subsidiary, specialized in hemodialysis care, to better serve our patients.

2006

Opening of the first massive solutions unit using the BFS system, innovating in the healthcare domain.

2006

Expansion of the company's hospital offering, enabling response to a broader range of medical needs.

2008

Launch of the third production unit for small volumes, increasing our capacity to respond to market demands.

2011

In-depth study for expanding BFS system production capacities, aimed at improving our efficiency.

2016

Entry into production of the fourth massive solutions unit, strengthening our market position.

2020

Entry into production of a new unit dedicated to hemodialysis concentrates, responding to the growing needs of patients.

Our Team

For over 30 years, IMC has strived to maintain impeccable quality in the production of single-use medical devices. We have implemented rigorous controls at every stage, from design to distribution, to ensure that our products not only meet international standards but also provide real added value to our patients.

The strength of IMC lies in our ability to innovate continuously while remaining true to our commitment to safety and efficiency. Each new product is the result of close collaboration between our engineers, technicians, and medical experts. We are constantly listening to feedback from our healthcare partners to refine our devices to meet the specific needs of patients.

Our commitment to excellence and continuous innovation has allowed us to become a leader in our field. We constantly invest in research and development to improve our manufacturing processes and develop new solutions that address the current challenges in the medical sector. Our goal is to continue pushing the boundaries of what is possible in healthcare.

Amir Benyahia

General Director

Fatima Belkacem

Operations Director

Karim Mansouri

R&D Director